Ingenus Pharmaceuticals

Ingenus Pharmaceuticals, established in 2010, is a privately owned pharmaceutical company based in the United States. The company specializes in the development, manufacturing, and commercialization of high-quality generic medications, emphasizing cost-effective solutions for patients, suppliers, and stakeholders. Ingenus Pharmaceuticals operates corporate headquarters in Orlando, Florida, with additional locations in Denville, New Jersey; Fairfield, New Jersey; Hyderabad, India; and Lugano, Switzerland. The research and development facilities, known as RiconPharma, are situated in Denville, New Jersey, and Hyderabad, India, while the manufacturing facilities are located in Fairfield, New Jersey, and Lugano, Switzerland. The New Jersey manufacturing plant focuses on finished solid oral dosage forms and is USFDA registered and FDA inspected. The Switzerland plant, accredited by SwissMedic, specializes in oncology finished dosage forms and cytotoxic sterile injectable products in liquid and lyophilized forms. Ingenus Pharmaceuticals offers a broad range of generic medications, including oral solids and oncology products, and maintains a strong network of strategic partners for marketing and manufacturing. The company’s product portfolio includes Arsenic Trioxide Injection, Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride Capsules, among others. Known for its high quality standards, Ingenus Pharmaceuticals is dedicated to improving patient access to medications and operates under the philosophy of quality over quantity. The company is also committed to fostering a culture of diversity, equity, and inclusion, and has been recognized with the Cigna Healthy Workforce Designation.